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 ABSTRACT 
Objectives 
To determine the effect of Adaptive Statistical Iterative Reconstruction (ASIR) on 
perfusion CT (pCT) parameter quantitation and image quality in primary colorectal 
cancer. 
Methods 
Prospective observational study. Following institutional review board approval and 
informed consent, 32 patients with colorectal adenocarcinoma underwent pCT (100 
kV, 150 mA, 120 second acquisition, axial mode). Tumour regional blood flow (BF), 
blood volume (BV), mean transit time (MTT) and permeability surface area product 
(PS) were determined using identical regions-of-interests for ASIR percentages of 
0%, 20%, 40%, 60%, 80% and 100%. Image noise, contrast-to-noise ratio (CNR) 
and pCT parameters were assessed across ASIR percentages. Coefficients of 
variation (CV), repeated measures analysis of variance (rANOVA) and Spearman’ 
rank order correlation were performed with statistical significance at 5%. 
Results 
With increasing ASIR percentages, image noise decreased by 33% while CNR 
increased by 61%; peak tumour CNR was greater than 1.5 with 60% ASIR and 
above. Mean BF, BV, MTT and PS differed by less than 1.8%, 2.9%, 2.5% and 2.6% 
across ASIR percentages. CV were 4.9%, 4.2%, 3.3% and 7.9%; rANOVA P values: 
0.85, 0.62, 0.02 and 0.81 respectively.  
Conclusions 
ASIR improves image noise and CNR without altering pCT parameters substantially.  
Highlights 
• Quantitative Perfusion CT parameters are not affected substantially by 
increasing ASIR levels.  
• ASIR improves image noise and CNR at a reduced peak kilovoltage of 100kV. 
Peak tumour CNR is greater than 1.5 with 60% ASIR and above. 
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INTRODUCTION 
Perfusion computed tomography (pCT) techniques enable in-vivo tumour 
vascularisation to be evaluated in clinical practice (1). Regional blood flow (BF), 
blood volume (BV) and permeability surface area product (PS), derived from the 
temporal changes in vascular and tissue attenuation following an intravenous bolus 
injection of standard CT iodinated contrast agent, act as surrogate measures of 
tumour angiogenesis and perfusion-related hypoxia across different tumour types (2-
6). Perfusion CT is clinically relevant in colorectal cancer. Staging blood flow is lower 
in patients with nodal metastases (7), those who subsequently present with 
metastases despite curative surgery (8), and those who have a poorer overall 
survival (7). This is thought to reflect perfusion-related hypoxia, supporting the use of 
pCT in oncologic clinical trials as a prognostic and response biomarker (1). 
In recent years, the clinical emphasis on dose-reduction has led all major CT 
manufacturers to implement hybrid iterative image reconstruction techniques instead 
of traditional analytical filtered back projection (FBP) reconstruction, in order to 
compensate for the increase in image noise with low-dose CT acquisitions. These 
hybrid algorithms combine analytical and iterative methods in a number of ways. 
Adaptive statistical iterative reconstruction (ASIR) uses the image information 
obtained from FBP as an initial building block for further iterative reconstruction to 
improve image characteristics, including noise. This has enabled dose reductions 
between 32% and 65% in phantom studies without substantially affecting image 
quality (9, 10) subsequently confirmed by clinical studies, both paediatric (11-13) and 
adult (14-21). The impact of iterative reconstruction techniques on quantitative pCT 
analysis has not been investigated and is clinically relevant, given their widespread 
use. The aim of this prospective study was to assess the effect of ASIR on image 
quality and pCT quantitation in primary colorectal cancer. 
 
MATERIALS AND METHODS 
Patients 
Institutional review board approval and written informed consent were obtained 
prospectively for this single-centre observational study, as part of a multicentre NIHR 
HTA funded study aimed at evaluating a prognostic model of conventional predictive 
variables and novel variables derived from pCT to improve the prediction of 
metastatic disease in primary colorectal cancer. Inclusion criteria were adult patients 
with a diagnosis of colorectal cancer. Exclusion criteria were standard 
contraindications to iodinated contrast agent (including previous iodinated contrast 
agent reaction, impaired renal function, lack of intravenous access) and no visible 
tumour on the planning CT acquisition. Thirty-four patients agreed to participate from 
January 2012 to July 2014. In two patients technical errors precluded analysis, 
leaving 32 patients (27 men, 5 women) in this study group. Mean (SD) patient age 
was 71.3 years ± 10.5 (men: 71.1 years ± 10.6; range, 38-91 years; women: 72.2 ± 
11.5; range, 54-84 years). Mean (SD) patient size, measured in the axial plane 
immediately cranially to the iliac crest, was 24.28 ± 3.23 cm (latero-lateral; range, 
17.89-31.06 cm) x 35.67 ± 2.73 cm (antero-posterior; range, 30.45-40.99). Tumours 
had a mean diameter of 4.5 cm ± 2.1 (range, 2.0 - 10.1 cm) and were located as 
follows: cecum (5), ascending colon (4), descending colon (1), sigmoid colon (7), 
rectum (15). Radiological tumour (T) and nodal (N) staging, evaluated on CT images 
only and based on the UICC TNM Classification of Malignant Tumours, Seventh 
Edition, was as follows: T2 (12), T3 (17), T4 (3), N0 (16), N1 (11), N2 (5). 
 CT Perfusion Technique 
To minimise bowel peristaltic movement, 20 mg of the spasmolytic agent hyoscine 
butylbromide (Buscopan; Boehringer Ingelheim, Ingelheim am Rhein, Germany) 
were administered intravenously prior to data acquisition unless contraindicated. 
Perfusion CT was performed on a Discovery 750 HD multi-detector CT(GE 
Healthcare, Waukesha, USA). An initial low dose abdominal or pelvic planning 
sequence was performed, without intravenous contrast material, to locate the 
colorectal tumour (100 kV, 50 mA with smart mA, 5-mm slice collimation, 50-cm scan 
field of view, 512 x 512 mm matrix). The tumour was identified by the supervising 
radiologist and the acquisition coordinates were used to plan the subsequent 
dynamic pCT acquisition, which was centred at mid-tumour level. 50 mL of 370 
mg/mL iodinated contrast agent (Niopam, Bracco S.p.A, Milan, Italy) were injected 
intravenously through a pump injector (Medrad Stellant dual syringe, Bayer 
Healthcare, Leverkusen, Germany) at a rate of 5 mL/sec, followed by a 50 ml saline 
chaser injected at the same rate. The pCT acquisition consisted of 8 contiguous 5 
mm slices (4 cm z-axis coverage), obtained at 1.5 sec intervals for 45 sec (perfusion 
phase) and at 15 sec intervals for a further 75 sec (interstitial phase), giving a total 
number of 35 acquisition time points with the following acquisition parameters: 100 
kV; 150 mA without tube current modulation; axial mode; 0.5 sec rotation time ; 50 
cm scan field of view; 512 x 512 mm matrix; B30 soft reconstruction kernel; 10 sec 
delay after IV contrast agent injection; breath intermittently held in expiration during 
the perfusion and interstitial phase to minimise respiratory excursion. Mean CTDIVol 
and DLP were 137.8 ± 15.3 mGy and 551.0 ± 61.2 mGy∙cm respectively. 
 
Image Analysis 
All pCT acquisitions were reconstructed at 6 different ASIR percentages: 0% ASIR 
(equivalent to FBP) and with increasing percentages of 20%, 40%, 60%, 80% and 
100% ASIR, resulting in 6 separate pCT datasets per patient (Figure 1). With the 
aim of eliminating interobserver variability, image data were analysed by two readers 
in consensus [with 1 year (SV) and >15 years’ (VG) CT perfusion experience 
respectively] on a workstation (Advantage Windows 4.6; GE Healthcare, Chicago, 
USA) using commercial perfusion software (Perfusion 4; GE Healthcare, Chicago, 
USA). A processing threshold of -50 to 150 HU was chosen to optimise soft tissue 
visualisation. No motion correction algorithm was applied. An arterial input was 
defined by placing a 1 cm2 circular region-of-interest (ROI) within the best visualised 
artery (aorta, iliac, or femoral) to derive the arterial time-enhancement curve. 
Parametric maps (BF, BV, MTT and PS) were generated, with each pixel 
representing a parameter value, based on the maximum slope method algorithm and 
a modified Johnson and Wilson distributed parameter model (GE Healthcare, 
Chicago, USA). A tumour ROI was outlined on each axial image where tumour was 
visualised, ensuring that the entire tumour was encompassed within the ROIs; 
luminal gas was excluded where present.  
The analysis of 0% ASIR images was conducted first; the delineated ROIs were 
saved by the software to allow these to be propagated onto subsequent datasets 
with different ASIR percentages (20-100%), thus avoiding any measurement 
variation related to ROI placement. The mean values for each of the four tumour 
pCT parameters – BF, BV, MTT and PS - were recorded. The entire process was 
repeated in the same manner for each patient and for all the subsequent ASIR 
datasets- 20%, 40%, 60%, 80% and 100% - using the exact same ROI. 
 Assessment of Image Quality 
Image noise and contrast to noise ratio (CNR) were calculated from the grey-scale 
images. For each patient and ASIR percentage, tumour baseline density and peak 
enhancement were recorded from the tissue time-density curve on a single gray-
scale image; a fixed circular 1 cm2 ROI was placed on skeletal muscle and the 
Hounsfield unit (HU) standard deviation recorded to provide a measure of image 
noise. CNR was calculated by dividing tumour enhancement (tumour peak 
enhancement - baseline density) by the muscle ROI standard deviation. 
 
Statistical Analysis 
The mean and standard deviation for each pCT parameter, image noise and CNR 
were calculated for the different ASIR percentages (0-100%). Within-patient 
coefficients of variation (CV) were calculated for each parameter across the different 
ASIR percentages (standard deviation divided by mean), and expressed as a 
percentage value. Repeated measures analysis of variance (rANOVA) of pCT 
parameters was performed, using Greenhouse-Geisser (GG) correction when 
appropriate based on Mauchly’s test of sphericity, and followed by post hoc testing 
using the Bonferroni method. Spearman rank order correlation was performed to 
assess the associations of image noise and CNR with ASIR percentage. Statistical 
significance was assigned at the 5% level. Statistical analysis was performed using 
IBM SPSS Statistics, Version 22 (IBM Corporation, New York, USA). 
 
Sample Size Justification 
Retrospective power analysis under the guidance of a statistician (GPower 3.1) 
showed that, with a 5% significance level and 90% power, 13 subjects would be 
required to be able to detect a difference of 7 units between two sets of parameter 
measurements (based on BF values), equivalent to a clinically significant 10% 
variation. Our actual sample size of 32 meets these criteria with ample margins. 
 
RESULTS 
Image quality 
Mean image noise (±standard deviation) decreased with increasing ASIR 
percentages, changing from 27.06 ± 4.57 (range, 15.32-38.00) at 0% ASIR to 18.16 
± 4.41 (range, 10.08-28.01) at 100% ASIR, a relative decrease of 32.8%. Mean 
tumour enhancement remained relatively stable across ASIR levels, ranging on 
average between 33.01 ± 4.94 HU and 35.59 ± 8.47 HU (a relative change of 7.8%). 
Consequently, mean CNR increased from 1.22 ± 1.08 (range, 0.18-4.59) to 1.96 ± 
1.92 (range, 0.21-9.23), a relative increase of 60.7% (Table 1, Figure 2). As 
expected, there was a strong negative rank correlation between image noise and 
ASIR level (r = -0.639; P < 0.001); a weak positive rank correlation was found 
between CNR and ASIR level(r = 0.206; P = 0.004). 
 
Perfusion CT parameters 
Mean BF, BV, MTT, PS and coefficients of variation across increasing ASIR 
percentages are summarised in Table 2 and Figure 3. Mean parameter values 
differed by less than 1.8%, 2.9%, 2.5% and 2.6% for BF, BV, MTT and PS 
respectively across the different ASIR percentages. Coefficients of variation ranged 
between 3.3% and 7.9% for each of the parameters. Repeated measures ANOVA 
showed that mean BF, BV and PS measurements did not differ substantially, with P 
values of 0.85, 0.62 and 0.81 respectively. Mean MTT measurements yielded a P 
value of 0.02; post hoc tests using the Bonferroni correction, however, revealed no 
significant difference between pairs of ASIR levels (P values = 0.23 to 1.00). 
 
DISCUSSION 
In recent years there has been a step change in CT practice. The emphasis on dose 
reduction has led to the widespread implementation of hybrid iterative reconstruction 
techniques by all the major CT manufacturers, in order to improve or maintain image 
quality with low dose acquisitions. These hybrid algorithms combine filtered back 
projection data with iterative reconstruction methods. The potential impact of iterative 
reconstruction on quantitative perfusion CT techniques has not been explored for 
body tumours but is clearly relevant to oncologic imaging.  
In this study we showed that ASIR does not alter the tumour pCT parameters BF, BV 
and PS substantially, with repeated measurements ANOVA P values greater than 
0.6; MTT differed significantly between ASIR levels on ANOVA, though not so on 
post hoc pairwise comparisons; within-subject coefficients of variation for all 
parameters were smaller than 10%. 
Image noise and CNR improved with increasing levels of ASIR at a reduced peak 
kilovoltage of 100 kV, strengthening the case for the implementation of low dose CT 
perfusion protocols within the constraints of an adequate CNR for quantitation. 
Contrast enhancement within tumours, typically higher and more heterogeneous 
than in normal solid organs, altered by less than 8% across the different ASIR 
percentages. 
In general terms, the first stage of iterative reconstruction produces artificial raw data 
from the forward projection of a volumetric estimate taken from either an empty 
image or a FBP reconstruction.  Modelling of the volumetric estimate is then 
undertaken and the many possible path lengths, including the different angles and 
orientations, at which the x-ray photons could pass through the object are calculated; 
this way the estimate mimics a more realistic pathway in which the x-ray photons 
travel through the object to the detector; furthermore, instead of placing the initial 
location of the x-ray photons over a single point, like in FBP, it is placed over a small 
area. This artificial projection is then compared to the actual measurement to 
construct an updated image. Modification of this updated image is repeated a 
number of times until very little differences are present between the artificial 
projection and real measurement. In the last stage, the updated image is back 
projected onto the volumetric estimate. A phantom study comparing two first 
generation hybrid iterative reconstruction methods, ASIR and iDose, has shown they 
provide similar benefits, mainly acting on image noise reduction (22).  
Our results are in line with previous studies that have assessed the effect of 
commercially implemented iterative reconstruction techniques within normal organs. 
Studies have shown that iDose and AIDR did not substantially affect quantitative 
perfusion CT parameters in normal brain tissue (23, 24), normal liver (25) and 
normal pancreas (26), allowing dose reductions ranging between 20% and 56%. 
These hybrid algorithms are different to ASIR but have a similar aim of reducing 
noise. iDose implemented by Philips applies an optimal anatomical model in the 
image domain to iteratively eliminate the quantum image noise and attempts to 
maintain the appearance of a ‘full dose FBP image (27); in adaptive iterative dose 
reduction, AIDR implemented by Toshiba, statistical and scanner based models 
combined with projection noise estimation are applied to FBP reconstructions and 
followed by an iterative technique for optimisation (28).  
The reported coefficients of variation for CT Perfusion parameters (3.3% ~ 7.9%) are 
well within those previously reported for intra- and inter-observer variation, 
supporting their clinical acceptability; for example, a previous quantitative perfusion 
CT study in primary colorectal cancer reported mean intra-observer CV, based on 
same-study repeated measurements, ranging between 6.2% (PS) and 27.9% (BV) 
(28).   
ASIR levels of 30-50% have been shown to provide acceptable image noise and 
diagnostic confidence in abdominal CT without a substantial change in image 
appearance (18): these levels have been typically adopted in clinical practice for 
viewing purposes. Published phantom- and patient-based CT perfusion image 
quality assessments, for a reconstructed slice thickness of 5 mm in the pelvis, have 
shown typical peak CNR values greater than 1.5 at 100 kV (29). In our study, a CNR 
greater than 1.5 was achieved with ASIR levels of 60% and above: with the aim of 
striking a balance between achieving adequate CNR and avoiding major changes in 
image appearance, typical of pure ASIR algorithms, 60% will be our favored and 
recommended ASIR level for tumour CT perfusion analysis below 100kV in future 
studies, particularly for tumours located in the pelvis, representing 27 out of 32 
tumours in the current cohort (including rectum, sigmoid and cecum). 
A reduced peak kilovoltage of 100 kV was adopted instead of the ‘standard’ 120 kV 
previously used for quantitative perfusion analysis of colorectal tumours (30-32), 
aiming to strike a balance between dose reduction and clinically acceptable image 
quality in a typical patient cohort from the United Kingdom. 
The current study has a few limitations. We only assessed the effect of ASIR on 
image quality and pCT quantitation at fixed kV and mA levels, having to adhere to a 
fixed imaging protocol as part of a prospective multicentric study; ethical issues 
would have to be considered with repeated acquisitions at multiple kV or mA levels 
in the same patient. The patient cohort size (n = 32), albeit relatively small, has been 
shown to have >99.9% power, with a 5% significance level, to show a difference of 7 
units or more between two sets of parameter measurements, equivalent to the 
clinically acceptable 10% parameter variation (based on BF values). 
In summary we found that ASIR improves image noise and contrast-to-noise ratio 
and does not alter pCT tumour parameters substantially at a reduced peak 
kilovoltage of 100 kV. These supportive data strengthen the case for implementing 
lower dose pCT protocols in future clinical practice, within the constraints of an 
adequate CNR for quantification. 
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TABLES 
Table 1.  Mean ± SD for image noise and contrast to noise ratios for each ASIR 
percentage and the relative change between 0% and 100% ASIR are shown. Data 
are means ± standard deviations, with ranges in parentheses. 
 
Image 
quality 
ASIR percentage Relative 
change 
(%) 
0% 20% 40% 60% 80% 100%  
Noise 
 
27.06 
±4.57 
(15.32-
38.00) 
28.24 
±4.75 
(15.32-
38.71) 
24.37 
±4.32 
(13.83-
32.42) 
22.40 
±4.45 
(11.23-
33.74) 
19.64 
±3.72 
(10.34-
26.04) 
18.16 
±4.41 
(10.08-
28.01) - 32.8% 
Contrast 
to noise 
1.22 
±1.08 
(0.18-
4.59) 
1.20 
±1.12 
(0.16-
4.92) 
1.36 
±1.28 
(0.10-
5.73) 
1.53 
±1.48 
(0.21-
6.73) 
1.73 
±1.69 
(0.22-
7.90) 
1.96 
±1.92 
(0.21-
9.23) + 60.7% 
  
Table 2. Tumour perfusion CT measurements for each ASIR percentage, P values 
for repeated measures ANOVA and coefficients of variation (CV) are shown. Data 
are means ± standard deviations, with ranges in parentheses. 
 
 
 
  
Perfusion 
CT 
parameter  
ASIR percentage P- 
value 
CV 
(%) 0% 20% 40% 60% 80% 100% 
Blood flow 
(mL/min/ 
100g) 
68.08 
±20.31 
(42.17-
118.55) 
67.75 
±20.38 
(41.31-
114.99) 
67.51  
±20.62 
(41.18-
114.69) 
68.13 
±21.11 
(40.68-
126.09) 
67.18  
±20.10 
(41.95-
120.48) 
66.93  
±19.39 
(40.80-
112.45) 
0.85 4.9  
±3.4 
Blood 
volume 
(mL/100g) 
7.09 
±1.99 
(4.17-
11.35) 
7.01 
±1.99 
(3.88-
11.18) 
7.03  
±1.97 
(3.71-
12.05) 
7.15 
±1.96 
(3.84-
11.11) 
7.10 
±1.95 
(4.09-
10.92) 
7.12 
±2.03 
(3.90-
11.62) 
0.62 4.2 
±3.0 
Mean transit 
time (sec) 
7.54  
±1.15 
(4.70-
9.91) 
7.60 
±1.29 
(4.83-
9.87) 
7.62  
±1.20 
(4.84-
10.03) 
7.74  
±1.24 
(4.74-
9.96) 
7.74 
±1.21 
(4.78-
9.88) 
7.78 
±1.29 
(4.73-
10.01) 
0.02 3.3 
±2.3 
Permeability 
surface area 
product 
(mL/min/ 
100 g) 
32.51 
±7.65 
(18.54-
52.47) 
32.20 
±8.90 
(18.00-
52.82) 
32.03 
±8.84 
(18.73-
53.87) 
32.08 
±8.21 
(19.49-
51.32) 
32.82 
±9.17 
(15.78-
53.70) 
32.76 
±9.95 
(12.99-
59.52) 
0.81 7.9 
±3.6 
FIGURE LEGENDS 
Figure 1. Axial perfusion CT image reconstructed with 0% (A), 60% (B) and 100% 
ASIR (C). Parametric blood flow colour map (D). 
Figure 2. Box and whisker plots of perfusion CT parameters across increasing ASIR 
levels. Solid line in box represents median value, upper and lower bars represent 
first and third quartiles, whiskers represent 95% confidence intervals. P values of 
repeated measures ANOVA (with or without GG correction) are reported. 
Figure 3. Box and whisker plots of image noise and CNR across increasing ASIR 
levels. Solid line in box represents median value, upper and lower bars represent 
first and third quartiles, whiskers represent 95% confidence intervals. 
